.2021 .Management of symptomatic adult penile urethral arteriovenous malformation. ” Urology Case Reports, 101738 : 101738.
Uller W. .2014 .Arteriovenous malformations. ” Seminars in Pediatric Surgery, 07(2014) : 203-207.
Krol A,C.J. MacArthur. A . .Congenital hemangiomas: rapidly involuting and noninvoluting congenital hemangiomas. ” Archives of Facial Plastic Surgery, 7(2005) : 307-311.
Gibson C.R.,Barnacle A.M. . .Vascular anomalies: special considerations in children. ” CVIR Endovascular, 3(2020) : 60.
Lee A.,Patel N.A. .2021 .Systematic review of pediatric mandibular arteriovenous malformations. International Journal of Pediatric Otorhinolaryngology, 110942 : 110942.
Fourn Le .2014 .Efficacy and safety of embolization in arteriovenous malformations of the extremities and head and neck: a retrospective study of 32 cases. European Journal of Dermatology, 2450(2015) : 52-56.
Gabeff R. .2019 .Efficacy and tolerance of sirolimus (rapamycin) for extracranial arteriovenous malformations in children and adults. ” Acta Dermato-Venereologica, 99(12) : 00015555-3273.
Sethuraman G. . .Management of infantile hemangiomas: current trends. ” Journal of Cutaneous and Aesthetic Surgery, 7(2014) : 0974-2077.
Goss J.A. . .Propranolol treatment of vascular anomalies other than infantile hemangioma. ” Journal of Craniofacial Surgery, 28(2017) : 2001-2003.
Lu J. .2017 .Propranolol as a potentially novel treatment of arteriovenous malformations. ” JAAD Case Reports, 11(2018) : 355-358.
Pföhler C. .2013 .Successful treatment of a congenital extratruncal vascular malformation by orally administered propranolol. ” Journal of Dermatological Treatment, 869301(2015) : 59-62.
Kum J.J.,Khan Z.A. .2014 .Mechanisms of propranolol action in infantile hemangioma. ” Dermato-Endocrinology, 979699(2015) : e979699.
Padhiyar J.K. .2018 .Efficacy and safety of propranolol on the proliferative phase of infantile hemangioma: a hospital-based prospective study. Indian Journal of Paediatric Dermatology, 75 : 17-229.
Léauté-Labrèze C. .2008 .Propranolol for severe hemangiomas of infancy. ” New England Journal of Medicine, 358(24) : 2649-2651.
Mohanty P.K. . .A randomised controlled study on efficacy of propranolol, prednisolone and propranolol with prednisolone in infantile hemangioma. ” Journal of the Pediatrics Association, 7(2018) : 166.
Lee J.C. . .Propranolol therapy in infantile hemangioma: it is not just about the beta. ” Plastic and Reconstructive Surgery, 147(2021) : 875-885.
Rotter A.,Z.N.P. A. .2017 .Infantile hemangioma: pathogenesis and mechanisms of action of propranolol. ” Journal der Deutschen Dermatologischen Gesellschaft, 15(12) : 1185-1190.
Gupta R. . .Propranolol for vascular anomalies: efficacy and complications in pediatric patients. ” Journal of Indian Association of Pediatric Surgeons, 117(2023) : 22-205.
Page M.J. .2021 .The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. ” BMJ, 372 : n71.
Moola S. .2017 .Chapter 7: systematic reviews of etiology and risk.” JBI Manual for Evidence Synthesis. , : .
Higgins J.P.T.,Cochrane J.P.T. .2021 .Chapter 8: assessing risk of bias in a randomized trial. ” Cochrane Handbook for Systematic Reviews of Interventions, version 6, : .
Ong-A-Liem G.S. .2022 .Use of beta-blocker in cerebral proliferative angiopathy: a case report. ” Interdisciplinary Neurosurgery: Advanced Techniques and Case Management, 101663 : 101663.
Panda S.K. . .Propranolol in congenital hepatic arteriovenous malformation. Indian Journal of Pediatrics, 90(2023) : 952.
Chastanet S. .2022 .Effect of beta-blockers on extracranial arteriovenous malformations. ” Acta Dermato-Venereologica, 102 : 1412.
Ba H. .2020 .Beta blocker therapy for congenital hepatic arteriovenous fistula in two neonates. , 00163(2020) : 163.
J.W.C.H. . .Randomised controlled trial: can topical timolol maleate prevent complications for small superficial infantile haemangiomata in high-risk areas?” Pediatric Research. , 88(2020) : 756-760.
Diociaiuti A. .2020 .Cutaneous infantile haemangiomas with intracranial and intraspinal involvement: a European multicentre experience and review. ” Acta DermatoVenereologica, 100(16) : 00015555-3608.
Singh G. . .Oral propranolol in the treatment of ulcerated bleeding scrotal arteriovenous malformation. ” Journal of Indian Association of Pediatric Surgeons, 232(2020) : 19-403.
Tani S. .2020 .Change of serum cytokine profiles by propranolol treatment in patients with infantile hemangioma. ” Drug Discoveries and Therapeutics, 03014(2020) : 89-92.
Xu P. .2019 .Lip infantile hemangiomas involving the vermillion border have worse outcomes and prognosis to oral propranolol than lesions confined to one side of the vermillion. ” Journal of Oral and Maxillofacial Surgery, 09(2020) : 446-454.
Igarashi A. .2018 .A case of an infant with extremely low birth weight and hypothyroidism associated with massive cutaneous infantile hemangioma. ” Journal of Pediatric Endocrinology and Metabolism, 31(12) : 1377-1380.
Wu H.W. .2018 .Topical timolol vs. oral propranolol for the treatment of superficial infantile hemangiomas. ” Frontiers in Oncology, 00605(2018) : 605.
Xu M.N. . .Individualized treatment for infantile hemangioma. ” Journal of Craniofacial Surgery, 29(2018) : 1876-1879.
Kim K.H. .2017 .Comparison of efficacy and safety between propranolol and steroid for infantile hemangioma: a randomized clinical trial. ” JAMA Dermatology, 0250(2017) : 529-536.
Wang Y. . .Efficacy and safety of 2% topical propranolol cream for the treatment of proliferating infantile strawberry hemangiomas. Indian Journal of Pediatrics, 84(2017) : 425-429.
Yu X. . .LUMBAR syndrome: a case manifesting as cutaneous infantile hemangiomas of the lower extremity, perineum and gluteal region and a review of published work. ” Journal of Dermatology, 44(2017) : 13763-8138.
Macca L. .2022 .Update on treatment of infantile hemangiomas: what's new in the last five years?” Frontiers in Pharmacology. , 879602 : 879602.
Demirci O.,Celayir A. .2020 .Prenatal diagnosis and treatment of intrahepatic arteriovenous fistulas: case reports and the literature review. ” Journal of Maternal-Fetal and Neonatal Medicine, 1731466(2022) : 837-845.
Simsek E.,N Y Y Y Y Y Y Y E.,a N Y Y Y Y Y Y Y E.,N Y Y Y Y Y Y Y E. . .0 s s s s s s s a 02 o e. -0055, 31(2018) : 823-827.